Traditional Chinese medicine for treating hashimoto thyroiditis and preparation method thereof

Abstract

The invention relates to traditional Chinese medicine for treating hashimoto thyroiditis and a preparation method thereof. The traditional Chinese medicine for treating the hashimoto thyroiditis is prepared from, by weight, 8-22 parts of Chinese thorowax roots, 13-27 parts of spica prunellae, 5-17 parts of combined spicebush roots, 4-13 parts of fructus citri sarcodactylis, 3-11 parts of thunberg fritillary bulbs, 13-28 parts of figwort roots, 15-26 parts of radix rehmanniae, 12-27 parts of radix paeoniae alba, 10-26 parts of milkvetch roots, 6-16 parts of angelica sinensis, 5-15 parts of spina gleditsiae, 10-21 parts of herba taraxaci, 6-15 parts of folium isatidis, 5-13 parts of clematis roots and 6-14 parts of radix platycodonis. Water is added in a mixture of Chinese thorowax roots, combined spicebush roots, fructus citri sarcodactylis and angelica sinensis, distillation is conducted to extract volatile oil, inclusion of beta- cyclodextrin is conducted on the volatile oil for standby, dregs of a decoction is mixed with other drugs after distillation, water is added in the mixture, concentration is conducted after the mixture is decocted, concentration is conducted after alcohol precipitation is conducted on a concentrated solution, auxiliary materials are added after concentration, spray drying is conducted, and mixing and granulation are conducted on drug powder, a beta-cyclodextrin inclusion complex of the volatile oil and the like. The traditional Chinese medicine for treating the hashimoto thyroiditis has the effects of regulating Qi, smoothing depression, dissipating phlegm, clearing heat, resolving lumps and removing galls.

Description

Technical field [0001] The invention relates to a Chinese medicine, in particular to a Chinese medicine for treating Hashimoto's thyroiditis and a preparation method thereof. Background technique [0002] Chronic lymphocytic thyroiditis (Hashimotothyroiditis, HT) is a common disease and frequently-occurring disease. The incidence in my country is about 0.3-1.5 / 1000. It is more common in women, with a ratio of about 1:20. Among them, the peak period of onset is 30-60 years old, which can be seen in children and the elderly. At present, with the accelerated pace of life, increased work pressure, and changes in diet, the incidence of chronic lymphocytic thyroiditis (HT) is increasing year by year and becoming younger. At present, the treatment of chronic lymphocytic thyroiditis (HT) by western medicine mainly adopts thyroid hormone replacement therapy, immunotherapy and surgical treatment. Thyroid hormone replacement therapy cannot reduce the high titer of anti-thyroid autoantibodi...

AI Technical Summary

Problems solved by technology

Thyroid hormone replacement therapy cannot reduce the high titer of anti-thyroid autoantibodies in the patient's serum, and has little direct effect on the autoimmune pathogenic process of the patient

Adrenal cortex hormone therapy also requires long-term use, and its adverse reactions are manifold, and the recurrence rate is high

Images